Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001437749-17-017235

Options or other derivatives

  • Director acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Stein Robert Benjamin Director 2017-10-16 Grant or award · Non-Qualified Stock Options (Right to Buy() +200,000 200,000 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…